New Treatment Approved in Canada for Gastrointestinal Stromal Tumor
source: pixabay.com

New Treatment Approved in Canada for Gastrointestinal Stromal Tumor

According to a story from Biotech 365, the biopharmaceutical company Deciphera Pharmaceuticals has recently announced that the company's drug ripretinib (marketed as QINLOCK™) has been approved by Health Canada. The…

Continue Reading New Treatment Approved in Canada for Gastrointestinal Stromal Tumor
The First Treatment for Adult-Onset Still’s Disease Just Got FDA Approved
source: pixabay.com

The First Treatment for Adult-Onset Still’s Disease Just Got FDA Approved

According to a story from PR Newswire, the US Food and Drug Administration (FDA) has just approved a treatment for rare adult-onset Still's disease for the first time ever. The…

Continue Reading The First Treatment for Adult-Onset Still’s Disease Just Got FDA Approved
June is Scleroderma Awareness Month: Spreading Rare Disease Awareness
source: pixabay.com

June is Scleroderma Awareness Month: Spreading Rare Disease Awareness

According to a story from Scleroderma News, June is recognized as Scleroderma Awareness Month. While physical distancing as a result of the ongoing coronavirus/COVID-19 pandemic may keep some folks at…

Continue Reading June is Scleroderma Awareness Month: Spreading Rare Disease Awareness
On July 1, the Marfan Foundation and Loeys-Dietz Syndrome Foundation Will Officially Partner Up
rawpixel / Pixabay

On July 1, the Marfan Foundation and Loeys-Dietz Syndrome Foundation Will Officially Partner Up

Education, research, support, and patient advocacy: these are just four of the amazing things that rare disease or disorder foundations offer. Many foundations seek to offer programs and resources to…

Continue Reading On July 1, the Marfan Foundation and Loeys-Dietz Syndrome Foundation Will Officially Partner Up
FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis
source: pixabay.com

FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis

In a press release from Eli Lilly and Company, the company has announced recently that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (BLA)…

Continue Reading FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis
Consumers with Allergies, EoE Worry When FDA Relaxes Food Labeling Guidelines
https://pixabay.com/en/vegetables-carrot-food-healthy-1085063/

Consumers with Allergies, EoE Worry When FDA Relaxes Food Labeling Guidelines

  Stacey Saiontz is many things: a worker, a wife, a mother. But right now, she is concerned. As an allergy parent, or a parent whose child has severe food…

Continue Reading Consumers with Allergies, EoE Worry When FDA Relaxes Food Labeling Guidelines
The Very First Treatment for Neurofibromatosis Type 1 Has Been Approved by the FDA
source: pixabay.com

The Very First Treatment for Neurofibromatosis Type 1 Has Been Approved by the FDA

Neurofibromatosis  Neurofibromatosis is a rare condition that presents in different forms. Neurofibromatosis type one (NF1) causes tumors to grow on the plexiform neurofibromas, a type of nerve in the body. These tumors…

Continue Reading The Very First Treatment for Neurofibromatosis Type 1 Has Been Approved by the FDA
Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA
source: pixabay.com

Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA

According to a story from prnewswire.com, the Chiesi Global Rare Diseases and the biopharmaceutical company ProTalix Biotherapeutics have recently announced that they have submitted a Biologics License Application (BLA) for…

Continue Reading Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA
April is Parkinson’s Disease Awareness Month. Here’s How You Can Get Involved
source: pixabay.com

April is Parkinson’s Disease Awareness Month. Here’s How You Can Get Involved

The month of April is recognized as Parkinson's Disease Awareness Month. While Parkinson's disease is not considered rare, Patient Worthy chooses to continue to provide coverage of this illness because…

Continue Reading April is Parkinson’s Disease Awareness Month. Here’s How You Can Get Involved